Oras A Alabas

6PUBLICATIONS
18CO-AUTHORS
Immunogenetics (incl. genetic immunology)Gene and molecular therapyRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 29, 2025
Drug survival of IL-23 and IL-17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study.

Leila Motedayen Aval, Zenas Z N Yiu, Oras A Alabas

|Jan 10, 2025
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu

|Dec 05, 2023
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu

|Dec 11, 2021
Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis.

Sayam Dubash, Oras A Alabas, Xabier Michelena

Pageof 1

Frequent Collaborators

5 joint publications

Zenas Z N Yiu

3 joint publications

Richard B Warren

3 joint publications

Kayleigh J Mason

2 joint publications

Christopher E M Griffiths